These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
449 related articles for article (PubMed ID: 37239455)
1. The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy. Radosavljevic M; Svob Strac D; Jancic J; Samardzic J Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239455 [TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacogenetics and potential application in personalized medicine. Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611 [TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy. Bosch TM Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231 [TBL] [Abstract][Full Text] [Related]
4. Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders. Kirchheiner J; Bertilsson L; Bruus H; Wolff A; Roots I; Bauer M Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S235-43. PubMed ID: 14677085 [TBL] [Abstract][Full Text] [Related]
5. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes. Kirchheiner J; Seeringer A Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics and antidepressant drugs. Binder EB; Holsboer F Ann Med; 2006; 38(2):82-94. PubMed ID: 16581694 [TBL] [Abstract][Full Text] [Related]
7. The role of pharmacogenetics in the treatment of depression and anxiety disorders. Schosser A; Kasper S Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481 [TBL] [Abstract][Full Text] [Related]
13. Role of pharmacogenetics in irinotecan therapy. de Jong FA; de Jonge MJ; Verweij J; Mathijssen RH Cancer Lett; 2006 Mar; 234(1):90-106. PubMed ID: 16343744 [TBL] [Abstract][Full Text] [Related]
14. The usefulness of genotyping cytochrome P450 enzymes in the treatment of depression. Dubovsky SL Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):369-79. PubMed ID: 25554071 [TBL] [Abstract][Full Text] [Related]
16. [Current topics in pharmacokinetics and pharmacogenetics of antidepressant drugs]. Gex-Fabry M; Bertschy G; Kosel M; Ferrero F Rev Med Suisse; 2009 Sep; 5(217):1808, 1810-3. PubMed ID: 19839368 [TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression. Islam F; Gorbovskaya I; Müller DJ Adv Exp Med Biol; 2021; 1305():231-255. PubMed ID: 33834403 [TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Bosch TM; Meijerman I; Beijnen JH; Schellens JH Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759 [TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic and drug interaction aspects on ketamine safety in its use as antidepressant - implications for precision dosing in a global perspective. Langmia IM; Just KS; Yamoune S; Müller JP; Stingl JC Br J Clin Pharmacol; 2022 Dec; 88(12):5149-5165. PubMed ID: 35863300 [TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of antidepressant treatment in obsessive-compulsive disorder: an update and implications for clinicians. Zai G; Brandl EJ; Müller DJ; Richter MA; Kennedy JL Pharmacogenomics; 2014 Jun; 15(8):1147-57. PubMed ID: 25084207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]